NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Old Version 1

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

compared with

New Version Current

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Revised to be consistent.
FieldDescription
Submission Type
Indicates whether the trial is an original submission, an update, or an amendment

The

Include Page
Trial Attribute Submission Type CAA - Include v4.4
Trial Attribute Submission Type CAA - Include v4.4

For information, refer to Processing Trial History Information (original versus amendment) or Abstracting NCI-Specific Information (Complete versus Abbreviated).

NCI ID
Identifier assigned to the trial by the CTRP.

The

Include Page
Trial Attribute NCI ID - Include v4.4
Trial Attribute NCI ID - Include v4.4

Info
titleNCI Trial Identifiers

The prefix "NCI" is implicit in the NCI trial identifiers.

ClinicalTrials.gov Identifier
Identifier assigned to the trial by the National Clinical Trial program (ClinicalTrials.gov). Trials with this number have been submitted to ClinicalTrials.gov previously.

The

Include Page
Trial Attribute NCT ID - Include v4.4
Trial Attribute NCT ID - Include v4.4
For details, refer to Abstracting Trial Descriptions, Titles, and Identifiers.

CTEP ID

The

Include Page
Trial Attribute CTEP ID - Include v4.4
Trial Attribute CTEP ID - Include v4.4
For details, refer to Abstracting Trial Descriptions, Titles, and Identifiers.

DCP ID

The

Include Page
Trial Attribute DCP ID - Include v4.4
Trial Attribute DCP ID - Include v4.4
For details, refer to Abstracting Trial Descriptions, Titles, and Identifiers

CTEP IDIdentifies trials submitted by CTEP (Clinical Therapy Evaluation Program).DCP IDIdentifies trials submitted by DCP (Division of Cancer Prevention)

.

CDR ID (PDQ ID)
Number

The number assigned to trials in the Clinical Data Repository. For details, refer to Abstracting Interventions.

Submitting Organization

The

Include Page
Trial Attribute Submitting Organization - Include v4.4

Organization that submitted the trial to CTRP.

Submission Date

Date on which the organization submitted the trial.

Amendment #

If the trial submitter has amended the trial, this number indicates the number of submissions.

Trial Category

Data Table 4 trial submission category, either Complete (National, Externally Peer-Reviewed, or Institutional trials), or Abbreviated (Industrial trials).

Trial Attribute Submitting Organization - Include v4.4

Submission Date

The

Include Page
Trial Attribute Submitted On - Include v4.4
Trial Attribute Submitted On - Include v4.4

Amendment #

Include Page
Trial Attribute Amendment Number - Include v4.4
Trial Attribute Amendment Number - Include v4.4
For instructions on revising this value, refer to Editing Trial Submission History.

Trial Category

The

Include Page
Trial Attribute Study Source Category - Include v4.4
Trial Attribute Study Source Category - Include v4.4
For information, refer to CTRP Trial Categories, Study Sources and Abstracting NCI-Specific Information.

Trial Type

The

Include Page
Trial Attribute Trial Type - Include v4.4
Trial Attribute Trial Type - Include v4.4
For information, refer to Trial Types and Subtypes, Abstracting Interventional Trial Design, and Abstracting Non-Interventional Trial Design

Trial TypeIndicates whether the trial is Interventional or Observational

.

Data Table 4 Funding
Indicates the funding source (Data Table 4 Funding Category). Values are: National, Externally Peer-Reviewed, Institutional, and Industrial/Other

The

Include Page
Trial Attribute Study Source DT4 Funding - Include v4.4
Trial Attribute Study Source DT4 Funding - Include v4.4
For information, refer to CTRP Trial Categories, Study Sources and Abstracting NCI-Specific Information.

On Hold Date
Date

The date on which the abstractor put the trial on hold, if applicable. For details, refer to Putting Trial Processing On Hold.

Off Hold Date
Date

The date on which the abstractor took the trial off hold, if applicable. For details, refer to Putting Trial Processing On Hold.

On Hold Reason

The

Include Page

Reason why the abstractor put the trial on hold, if applicable

Trial Attribute Hold Reason - Include v4.4
Trial Attribute Hold Reason - Include v4.4
For details, refer to Putting Trial Processing On Hold.

NCI Sponsored?
Indicates whether or not NCI sponsored the trial

An indication

Include Page
Trial Attribute NCI Sponsored - Include v4.4
Trial Attribute NCI Sponsored - Include v4.4
For details, refer to Abstracting Sponsors and Responsible Parties.

Assigned To

Displays

the name of the user assigned to the trial by a Super Abstractor

Include Page
Trial Attribute Assigned To - Include v4.4
Trial Attribute Assigned To - Include v4.4
Only users with the Super Abstractor role can assign a trial to another PA user. For information, refer to Assigning Trials to Abstractors.

Submission Source

The

means by which the trial was submitted to the CTRP:
  • Batch: Trials submitted via the NCI CTRP Registration Batch Upload site
  • ClinicalTrials.gov: Trials imported from ClinicalTrials.gov
  • Grid Service: Trials submitted via the NCI CTRP web services
  • PDQ: Trials submitted via the NCI Physician Data Query database
  • Registry: Trials submitted via Registration
  • REST Service: Trials submitted via NCI CTRP Registration REST Service
  • Other: Trials submitted via any method other than those listed above

Include Page
Trial Attribute Submission Source - Include v4.4
Trial Attribute Submission Source - Include v4.4

Processing Priority

The

Include Page
Trial Attribute Processing Priority - Include v4.4
Trial Attribute Processing Priority - Include v4.4
Only users with the Super Abstractor role can assign a priority to a trial. For information, refer to Assigning Trial Priorities.

Trial Processing Comments

Any

Include Page
Trial Attribute Processing Comments - Include v4.4
Trial Attribute Processing Comments - Include v4.4
This field also allows

Processing Priority

Indicates the importance assigned to the trial by a Super Abstractor:

  • 1 = High
  • 2 = Normal
  • 3 = Low
Trial Processing CommentsDisplays comments that an abstractor may have recorded previously, and enables

you to enter new comments about the trial

. (Limited to 4000 characters.)

. An abstractor can also add comments on the Trial Identification page. For information, refer to Viewing Trial Identification Details.

Processing Status

The

Include Page
Trial Attribute Current Trial Processing Status - Include v4.4
Trial Attribute Current Trial Processing Status - Include v4.4
For information, refer to Trial Processing Statuses and Abstracting Trial Statuses

Processing StatusRelative stage of the trial processing workflow

.

Processing Status Date
Date

The date on which the current processing status was recorded.

Admin Check-out

The Administrative Abstractor who has the trial checked out currently (if applicable). For details, refer to Checking In and Checking Out Trials.

Scientific Check-out

The Scientific Abstractor who has the trial checked out currently (if applicable). For details, refer to Checking In and Checking Out Trials.

Milestone (table)
Lists

A list of the milestones recorded to date. For details, refer to Processing Trial Milestones.